Exclusive

Publication

Byline

Oruka Therapeutics Stock Jumps 12% After Positive Phase 2b Psoriasis Trial

India, Oct. 26 -- Oruka Therapeutics, Inc. (ORKA) is up 11.69 percent, gaining $9.37 to $89.52 on Monday. The rise follows positive Week 16 results from the company's EVERLAST-B Phase 2b trial evaluat... Read More


Can-Fite Presents Final Phase 2a Data For Namodenoson In Pancreatic Cancer

India, Oct. 26 -- Can-Fite BioPharma Ltd. (CANF), a clinical-stage biotechnology company developing small molecule therapeutics, announced the final data from its Phase 2a clinical study of namodenoso... Read More


INR extends downside in narrow range

Mumbai, Oct. 26 -- The Indian rupee traded in a narrow range and fell 5 paise to 94.98 against the US dollar in early trade on Monday, weighed down by elevated crude oil prices and geopolitical tensio... Read More


Festive season 2026 car discounts: Here's what carmakers are offering

India, Oct. 26 -- Major carmakers are offering festive-season benefits across their Indian line-ups in October 2026, with the listed savings reaching Rs.2.75 lakh on select electric SUVs. The offers c... Read More


Gov Uzodimma proposes national media research centre in honour of Dokpesi

Nigeria, Oct. 26 -- Imo State Governor Hope Uzodimma has proposed establishing a national media centre in honour of the late founder of DAAR Communications Plc, Raymond Dokpesi. Mr Uzodimma proposed ... Read More


JUONE App: ఆహారం నుంచి ఆరోగ్యం వరకు- ఒకే యాప్‌లో అన్ని రకాల సేవలు- జూవన్ సూపర్ యాప్ లాంచ్ చేసిన సీనియర్ హీరోయిన్ ఇంద్రజ

భారతదేశం, అక్టోబర్ 26 -- Actress Indraja Launch JUONE App: రోజువారీ జీవితంలో ఎదురయ్యే అనేక అవసరాలకు వేర్వేరు యాప్‌లను ఉపయోగించే రోజులకు స్వస్తి పలుకుతూ.. అన్ని రకాల సేవలను ఒకే వేదికపై అందించాలనే లక్ష్... Read More


Anthropic Announces SEC Filing For Proposed IPO

India, Oct. 26 -- Monday, Anthropic (ANT) announced its plan to list its Class A common stock on the Nasdaq Global Select Market under the symbol 'ANT.' As part of the plan, the AI giant has filed a ... Read More


Biohaven's BHV-1420 Targets PLA2R Autoantibodies In Membranous Nephropathy

India, Oct. 26 -- Biohaven Ltd. (BHVN) presented preclinical data for BHV-1420, an investigational drug designed to selectively remove the autoantibodies that drive membranous nephropathy, at the Amer... Read More


Bayer's Asundexian Becomes First Factor XIa Inhibitor Approved In China For Stroke Prevention

India, Oct. 26 -- Bayer said China's National Medical Products Administration (NMPA) has approved Asundexian 50 mg, marketed as Sunharbo, to reduce the risk of stroke in adults who have experienced a ... Read More


Doctor outlines seasonal allergy triggers and home steps to manage symptoms

India, Oct. 26 -- Respiratory medicine expert Dr Rominder Kaur said seasonal allergies often rise with the October change in weather and can be mistaken for a seasonal cold, but in many cases “there i... Read More